Decreasing Rate of Multiple Treatment Modifications among Individuals who Initiated Antiretroviral Therapy in 1997–2009 in the Danish HIV Cohort Study

Abstract

Background

We hypothesized that rates and reasons for treatment modifications have changed since the implementation of combination antiretroviral therapy (cART) due to improvements in therapy.

Methods

From a nationwide population-based cohort study we identified all HIV-1-infected adults who initiated cART in Denmark 1997–2009 and were followed ≥1 year. Incidence rate ratios (IRRs) and reasons for treatment modifications were estimated and compared between patients, who initiated treatment in 1997–1999, 2000–2004 and 2005–2009. Rates of discontinuation of individual antiretroviral drugs (ARVs) were evaluated.

Results

A total of 3,107 patients were followed for a median of 7.3 years (IQR 3.8–10.8). Rates of first treatment modification ≤1 year after cART initiation did not change (IRR 0.88 [95% CI 0.78, 1.01] and 1.03 [95% CI 0.90, 1.18] in 2000–2004 and 2005–2009, respectively, compared with 1997–1999). Rates of multiple modifications decreased markedly (2000–2004 IRR 0.60 [95% CI 0.53, 0.67] and 2005–2009 IRR 0.38 [95% CI 0.32, 0.46]). Rates of treatment modifications due to virological failure, toxicity and other/unknown reasons decreased (IRR 0.25 [95% CI 0.14, 0.45], 0.69 [95% CI 0.56, 0.83] and 0.45 [95% CI 0.36, 0.57], respectively, in 2005–2009 compared with 1997–1999), whereas the rate of modifications with the aim of simplification increased (IRR 1.85 [95% CI 1.52, 2.25]).

Conclusions

Rates of first treatment modification ≤1 year after cART initiation have not changed since the early cART era, whereas the risk of multiple modifications has decreased markedly. Modifications due to virological failure and toxicity have decreased substantially, whereas rates of switch to simpler and less toxic regimens have increased.